Immuneering Signs Clinical Supply Agreement With Regeneron To Evaluate IMM-1-104 Plus Libtayo
Immuneering Corporation (IMRX), a clinical-stage oncology company, Thursday said it has signed a clinical supply agreement with ...
Immuneering Announces Clinical Supply Agreement with Regeneron Pharmaceuticals to Evaluate IMM-1-104 in Combination with Libtayo® (cemiplimab)
Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...
Should You Buy, Hold or Sell Leidos Stock Before Q4 Earnings Release?
Investors interested in LDOS may add this stock to their portfolio before Tuesday, considering its discounted valuation.
YunoJuno Releases 2025 Freelancer Rates Report: AI Skills Drive Shift in Contingent Workforce Market as Average Day Rates Rise
YunoJuno, the leading contingent workforce management platform connecting businesses with freelancers and contractors, this week released its comprehensive 2025 Freelancer Rates Report, revealing key ...